Medicine News and Research

RSS

HIF-1α protein can work directly to stop new cells from forming

A protein known for turning on genes to help cells survive low-oxygen conditions also slows down the copying of new DNA strands, thus shutting down the growth of new cells, Johns Hopkins researchers report. Their discovery has wide-ranging implications, they say, given the importance of this copying - known as DNA replication - and new cell growth to many of the body's functions and in such diseases as cancer.

23 Feb 2013

WHO must play 'assertive central role' in fighting distribution of substandard, fake medicines

This Lancet editorial notes the release of an Institute of Medicine (IOM) report commissioned by the Food and Drug Administration (FDA) that gathers information on "the global threat of falsified or substandard drugs" and provides recommendations "to mitigate this public health problem."

23 Feb 2013

Leading cancer researcher, Dr. Lewis Cantley, named a winner of the inaugural Breakthrough Prize in Life Sciences

Dr. Lewis Cantley, a leading cancer researcher credited with discovering a family of enzymes fundamental to understanding cancer, was named a winner of the inaugural Breakthrough Prize in Life Sciences, the world’s richest academic prize for medicine and biology. The prize, which carries a $3 million cash award, recognizes excellence in research aimed at curing intractable diseases and human life.

22 Feb 2013

Marine-based active substances show promise against multiple myeloma

There is fierce competition in the ocean habitat. In order to survive there, marine organisms defend themselves against their rivals using an entire arsenal of chemical weapons. With the help of these substances they attack hostile cells, overcome their defence system and thus are interesting active substance candidates for cancer research.

22 Feb 2013

Physicians afraid to give thrombolytic drugs to pulmonary embolism patients for good reason

When doctors encounter a patient with a massive pulmonary embolism, they face a difficult choice: Is it wise to administer a drug that could save the patient's life, even though many people suffer life-threatening bleeding as a result? Based on new findings published in the American Journal of Medicine, Michigan State University researchers are answering that question in no uncertain terms.

22 Feb 2013

Evolution of PEPFAR necessary for continued success

PEPFAR has "met or even surpassed most" of its "bold goals," including "saving the lives of millions of people; supporting the scale-up of HIV prevention, care, and treatment; and strengthening systems and policies for the HIV response," Robert Black of the Johns Hopkins Bloomberg School of Public Health writes in a Lancet opinion piece, noting the release of the Institute of Medicine's (IOM) "Evaluation of PEPFAR" on Wednesday.

22 Feb 2013

Florida Hospital Pepin Heart Institute, USF partner for novel gene therapy trial

Cardiovascular disease specialists at Florida Hospital Pepin Heart Institute and Dr. Kiran C. Patel Research Institute affiliated with the University of South Florida announced they have enrolled their first patients into a clinical trial testing a novel gene therapy for the treatment of heart failure after ischemic injury. The therapy may promote the regeneration of heart tissue by encouraging the body to deploy more stem cells to the injury site.

22 Feb 2013

Blog, forthcoming paper examine PEPFAR's 'financial flows'

Noting the release of the Institute of Medicine's PEPFAR evaluation and "our own work-in-progress on PEPFAR's value for money and data management," Victoria Fan, a research fellow at the Center for Global Development (CGD), and Rachel Silverman, a research assistant at CGD, highlight "two focus areas that ... are the subject of a forthcoming CGD policy paper on PEPFAR's financial flows" in a post on CGD's "Global Health Policy" blog.

22 Feb 2013

Team Danmark, Global Health Partner enter exclusive collaboration agreement

Through its subsidiary Gildhøj Privathospital, Global Health Partner is entering into an exclusive collaboration agreement with Team Danmark to provide Denmark's leading elite athletes with sports medicine and sports surgery.

22 Feb 2013

Study finds bariatric surgery does not reduce long-term medical costs

Research disputes widely-held beliefs that the weight-loss operations cut the need for treatments and medicine after patients shed pounds.

22 Feb 2013

Study shows how hyperparathyroidism affects people of different racial backgrounds

Unusually high calcium levels in the blood can almost always be traced to primary hyperparathyroidism, an undertreated, underreported condition that affects mainly women and the elderly, according to a new study by UCLA researchers.

22 Feb 2013

Research into why young adults overuse short-acting bronchodilators

The high cost of medication, stigmatisation and poor acceptance of their condition are causing young adults to take a dangerous approach to managing their asthma, according to new research published today in the journal BMJ Open.

22 Feb 2013

IntegraGen, Lab21 collaborate to develop new microRNA assay for colorectal cancer

Lab21 Limited, the global specialist in personalised medicine and clinical diagnostics, has entered into an agreement with IntegraGen, a leading player in the development and marketing of molecular diagnostic testing in autism and oncology, to develop a microRNA assay for colorectal cancer designed to further improve patient outcomes.

22 Feb 2013

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Breast cancer is a major concern throughout the world. It is the number 1 cancer among women and in the Western world it generates approximately one new case per minute: 24 hours a day 7 days a week.

22 Feb 2013

Major doctor group coalition expands list of tests, treatments that should be done only rarely

The American Board of Internal Medicine, as part of its "Choosing Wisely" campaign, expanded the number of medical societies recommending caution before certain tests and procedures are ordered.

22 Feb 2013

Researchers use 3D printing and injectable gels to create bioengineered ears

Physicians at Weill Cornell Medical College and biomedical engineers at Cornell University have succeeded in building a facsimile of a living human ear that looks and acts like a natural ear. Researchers believe their bioengineering method will finally succeed in the long quest by scientists and physicians to provide normal looking "new" ears to thousands of children born with a congenital ear deformity.

22 Feb 2013

Gladstone’s Senior Investigator honored for pioneering work in stem cell biology

Gladstone Institutes' Senior Investigator Shinya Yamanaka, MD, PhD, is one of 11 medical researchers to win a new, high-profile $3 million award from a group of high-tech sponsors, including the founders of Facebook and Google.

22 Feb 2013

Brain cooling after severe head injury may prevent epileptic seizures

In the weeks, months and years after a severe head injury, patients often experience epileptic seizures that are difficult to control. A new study in rats suggests that gently cooling the brain after injury may prevent these seizures.

22 Feb 2013

CB2 receptors might serve as potential therapeutic targets for cerebral ischemia

A new study published in the March issue of The American Journal of Pathology suggests that cortical type 2 cannabinoid (CB2) receptors might serve as potential therapeutic targets for cerebral ischemia.

22 Feb 2013

Viewpoints: Holtz-Eakin and Roy offer prescription to fix health law; Iowa lawmakers opposed to Medicaid expansion should give up their coverage

Over nearly a century, progressives have pressed for a national, single-payer healthcare system. When it comes to health reform, what have conservatives stood for? For far too long, conservatives have failed to coalesce around a long-term vision of what a free-market healthcare system should look like. ... Obamacare is the logical byproduct of this conservative policy neglect.

22 Feb 2013

Medicine News and Research

HIF-1α protein can work directly to stop new cells from forming

WHO must play 'assertive central role' in fighting distribution of substandard, fake medicines

Leading cancer researcher, Dr. Lewis Cantley, named a winner of the inaugural Breakthrough Prize in Life Sciences

Marine-based active substances show promise against multiple myeloma

Physicians afraid to give thrombolytic drugs to pulmonary embolism patients for good reason

Evolution of PEPFAR necessary for continued success

Florida Hospital Pepin Heart Institute, USF partner for novel gene therapy trial

Blog, forthcoming paper examine PEPFAR's 'financial flows'

Team Danmark, Global Health Partner enter exclusive collaboration agreement

Study finds bariatric surgery does not reduce long-term medical costs

Study shows how hyperparathyroidism affects people of different racial backgrounds

Research into why young adults overuse short-acting bronchodilators

IntegraGen, Lab21 collaborate to develop new microRNA assay for colorectal cancer

Breast cancer tests: an interview with Dr Steven Quay, CEO of Atossa Genetics

Major doctor group coalition expands list of tests, treatments that should be done only rarely

Researchers use 3D printing and injectable gels to create bioengineered ears

Gladstone’s Senior Investigator honored for pioneering work in stem cell biology

Brain cooling after severe head injury may prevent epileptic seizures

CB2 receptors might serve as potential therapeutic targets for cerebral ischemia

Viewpoints: Holtz-Eakin and Roy offer prescription to fix health law; Iowa lawmakers opposed to Medicaid expansion should give up their coverage

Industry Focus eBook - Cell & Gene Therapy (1st Edition) eBook

Improving healthcare sustainability through carbon data

Managing vibration in IVF laboratories

A New Approach to Preventing Bladder Cancer Recurrence

Latest News